Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 3Wilms Tumor 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioma 2Ependymoma 2Central Nervous System Neoplasms 2Xanthogranuloma, Juvenile 1Histiocytic Sarcoma 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

Gemcitabine 5Cisplatin 5Oxaliplatin 4pembrolizumab 3Irinotecan 3Carboplatin 3Specimen Handling 2Radiosurgery 2Psychiatric Rehabilitation 2Observation 2Magnetic Resonance Spectroscopy 2Leucovorin 2Floxuridine 2Erlotinib Hydrochloride 2Cyclophosphamide 2Cetuximab 2Bortezomib 2Blood Specimen Collection 2trastuzumab deruxtecan 1tislelizumab 1spartalizumab 1sodium thiosulfate 1selpercatinib 1rucaparib 1repotrectinib 1pidilizumab 1pazopanib 1p53 peptide 264-272, human 1motexafin lutetium 1montanide ISA 51 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × LY3023414 × Sarcoma × Clear all
NCT02784795 2025-08-21

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Eli Lilly and Company

Phase 1 Terminated
94 enrolled 28 charts
BreastGastrointestinalSarcoma

Breast Neoplasms, Colonic Neoplasms, Sarcoma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡